MicroRNA-3653-3p inhibited papillary thyroid carcinoma progression by regulating CRIPTO-1

Area of Science:

• Endocrinology
• Oncology
• Molecular Biology

Background:

• Papillary thyroid carcinoma (PTC) is the most common endocrine malignancy.
• Metastasis in PTC significantly worsens patient prognosis.
• Understanding the molecular mechanisms driving PTC progression is crucial for developing effective treatments.

Purpose of the Study:

• To investigate the role of miR-3653-3p in the progression of papillary thyroid carcinoma.
• To determine if miR-3653-3p influences PTC cell proliferation, migration, and invasion.
• To identify downstream targets of miR-3653-3p involved in PTC pathogenesis.

Main Methods:

• Quantitative Real Time-Polymerase Chain Reaction (qRT-PCR) to measure miR-3653-3p expression.
• Cell Counting Kit-8 (CCK-8), colony formation, transwell, and Matrigel assays to assess cell behavior.
• Dual-Luciferase reporter assay and Western blotting to identify and validate downstream targets.

Main Results:

• miR-3653-3p expression was found to be significantly downregulated in PTC tissues.
• Overexpression of miR-3653-3p suppressed PTC cell proliferation, migration, and invasion in vitro.
• CRIPTO-1 was identified as a direct downstream target of miR-3653-3p.

Conclusions:

• miR-3653-3p acts as a tumor suppressor in papillary thyroid carcinoma.
• The inhibitory effect of miR-3653-3p on PTC progression is mediated through the regulation of CRIPTO-1.
• miR-3653-3p and its regulatory pathway represent potential biomarkers and therapeutic targets for PTC.